Skip to content

Author

V. Raveendran

We have 1 of 29 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Advances in nucleotide-based P2Y₁ antagonism: implications for cardiovascular therapeutics.

Advances in P2Y₁R signaling, pharmacology, and structure-based design are integrated, emphasizing the evolution of nucleotide antagonists and their translational potential, and insights establish P2Y₁R antagonism as a promising strategy for next-generation cardiovascular therapeutics.

N. Erathodiyil, V. Raveendran, Jackie Y. Ying · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.